Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…
Articles by Marisa Wexler, MS
Xentria is seeking regulatory approval to begin clinical trials to test XTMAB-16, its investigational TNF-alpha inhibitor for the treatment…
Although uncommon, some people with cancer will develop granulomas, the clumps of immune cells that are a hallmark of…
The National Organization for Rare Disorders (NORD)’s RareLaunch training program will host two days of…
The World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) and the Foundation for Sarcoidosis Research (FSR) have recognized…
Relative to the general population, people with sarcoidosis are at higher long-term risk of heart failure and other heart…
A majority of rare disease patients using telehealth during the COVID-19 pandemic thought the experience positive, and many would like…
People with sarcoidosis are being asked to donate blood samples and information related to their disease to help the…
People with sarcoidosis who have impaired lung function seem to be at greater risk for severe COVID-19Â disease, a…
A grant from the Foundation for Sarcoidosis Research (FSR) will fund the development of a new mouse model of…